Update in cystic fibrosis 2005.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Effect of CFTR Modulators on Oxidative Stress and Autophagy in Non-CFTR-Expressing Cells.International journal of molecular sciences · 2024
   Article
2. Phenotypic and Genetic Characterization of Carbapenemase and ESBLs Producing Gram-negative Bacteria (GNB) Isolated from Patients with Cystic Fibrosis (CF) in Tehran Hospitals.Journal of clinical and diagnostic research : JCDR · 2014
   Article
3. Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator.Cell death and differentiation · 2013
   Article
4. Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.Autophagy · 2012
   Article
5. Caregiver perspectives on discussions about the use of intensive treatments in cystic fibrosis.Journal of pain and symptom management · 2010
   Article
6. In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients.Mediators of inflammation · 2010
   Article
7. Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers.International archives of medicine · 2008
   Article
8. A review of non-cystic fibrosis pediatric bronchiectasis.Clinical reviews in allergy & immunology · 2008
   Review
9. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.International journal of medical microbiology : IJMM · 2007
   Review
10. A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.American journal of physiology. Lung cellular and molecular physiology · 2007
    Article
11. Advanced lung organoids for respiratory system and pulmonary disease modeling.Journal of tissue engineering
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as